Aurobindo Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aurobindo Pharma Quarterly Results    (AUBD)

Here are the latest quarterly results of Aurobindo Pharma. For more details, see the Aurobindo Pharma financial fact sheet and Aurobindo Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aurobindo Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m42,50347,51452,69752,92254,44656,00557,99461,584 
Other income Rs m437263639323158206309326 
Turnover Rs m42,94047,77753,33553,24554,60456,21158,30461,910 
Expenses Rs m35,39237,65141,83342,34742,98244,60346,87048,422 
Gross profit Rs m7,1119,59410,61310,21511,33711,27511,95113,285 
Depreciation Rs m1,5451,6371,6311,8662,4092,4332,5012,324 
Interest Rs m295354477501499409371318 
Profit before tax Rs m5,7077,8669,1448,1708,5878,6389,38810,968 
Tax Rs m1,1551,7542,0482,3112,2782,2442,3292,285 
Profit after tax Rs m4,5526,1127,0965,8596,3106,3957,0608,683 
Gross profit margin %16.720.220.119.320.820.120.621.6 
Effective tax rate %20.222.322.428.326.526.024.820.8 
Net profit margin %10.712.913.511.111.611.412.214.1 
Diluted EPS Rs 7.8 10.4 12.1 10.0 10.8 10.9 12.1 14.8  
Diluted EPS (TTM) Rs 40.3 37.4 39.4 40.4 43.4 43.9 43.8 48.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Aurobindo Pharma 4QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AMAR REMEDIES  AJANTA PHARMA  SUN PHARMA  DISHMAN PHARMA  ALEMBIC LTD  

Compare AUROBINDO PHARMA With:   AMAR REMEDIES  AJANTA PHARMA  SUN PHARMA  DISHMAN PHARMA  ALEMBIC LTD  

Compare AUROBINDO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.

Views on news

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World (Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade? (Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jun 5, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - STERLING BIOTECH COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS